NCT01818869View on ClinicalTrials.gov

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Safety,Tolerability,Healthy Subjects
Interventions
DRUG

AZD8848

Multiple doses inhaled IMP via a nebulizer

DRUG

Placebo to match AZD8848

Multiple doses inhaled matching placebo via a nebulizer

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01818869 - To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects | Biotech Hunter | Biotech Hunter